Form 4: Nicole Seligman Receives 60,000 RSUs at MeiraGTx

Director Nicole Seligman was granted 60,000 restricted share units in MeiraGTx Holdings plc as part of annual compensation.

Summary

• Director Nicole Seligman received a grant of 60,000 restricted share units (RSUs) on June 11, 2026.
• Each RSU represents a right to receive one ordinary share of MeiraGTx Holdings plc upon settlement.
• The RSUs are scheduled to vest in a single installment on June 11, 2027, or the day before the 2027 annual shareholder meeting, whichever occurs first.
• The reporting person has elected to defer settlement of the shares until she ceases to be a director of the company.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial health.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• None identified.

Risks

• Future share price volatility may impact the ultimate value of the equity grant.

Future Outlook

The filing does not provide forward-looking financial guidance for the company.

Industry Context

StockSavvy.ai notes that equity grants to non-executive directors are standard corporate governance practice in the biotechnology sector to ensure board members maintain a vested interest in company performance.

Comparison to Industry Standards

• The grant of RSUs to directors is consistent with standard compensation practices for NASDAQ-listed biotechnology firms.
• The vesting schedule of one year is typical for annual director equity retainers.

Stakeholder Impact

• Minor dilution impact to existing shareholders upon eventual settlement of the RSUs.

Next Steps

• Vesting of 60,000 RSUs on June 11, 2027.

Key Dates

Keywords

MeiraGTx, MGTX, Insider Trading, Form 4, Director Compensation, Restricted Share Units